Chemomab News and Activities

Chemomab is a company listed under the stock ticker CMMB (IL).

View the org chart displaying its 10 main executives

Most searched biographies at Chemomab

• Adi Mor, Chief Executive Officer
• Neil Cohen, Director
• Alan Moses, Board Member

Create your alert
to follow the executive moves at Chemomab.

Chemomab has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Chemomab

• Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/III
• Chemomab Announces Poster Presentation at the International Liver Congress 2021 (EASL)
• Chemomab to Present at Oppenheimer's Virtual Rare and Orphan Disease Summit
• Chemomab Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update
• Chemomab Announces Enrollment of First Patient in Phase 2a Study of CM-101 in Non-Alcoholic Steatohepatitis (NASH)
• Chemomab Announces Four New Appointments to the Board of Directors and Completion of PIPE Financing
• View more press releases Close

Social media about Chemomab

• Chemomab on Wikipedia, Google News & Yahoo Finance
• Chemomab on LinkedIn, X (Twitter) & YouTube